Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects

The monkeypox disease (MPX) outbreak of 2022 has been reported in more than one hundred countries and is becoming a global concern. Unfortunately, only a few treatments, such as tecovirimat (TCV), are available against MPX. Brincidofovir (BCV) is a United States Food and Drug Administration (USFDA)-...

Descripción completa

Detalles Bibliográficos
Autores principales: Imran, Mohd., Alshammari, Mohammed Kanan, Arora, Mandeep Kumar, Dubey, Amit Kumar, Das, Sabya Sachi, Kamal, Mehnaz, Alqahtani, Abdulaziz Saad Abdulrahman, Sahloly, Mohammed Ahmed Yahya, Alshammari, Ahmed Hammad, Alhomam, Hessah Mohammed, Mahzari, Aeshah Mousa, Abida, Rabaan, Ali A., Dzinamarira, Tafadzwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953536/
https://www.ncbi.nlm.nih.gov/pubmed/36830816
http://dx.doi.org/10.3390/biomedicines11020278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953536/
https://www.ncbi.nlm.nih.gov/pubmed/36830816
http://dx.doi.org/10.3390/biomedicines11020278

Ejemplares similares